Medtronic win over NuVasive stands, but no injunction

January 27, 2012 by MassDevice staff

A federal judge declines to set aside Medtronic's $101 million patent win over NuVasive (or to quash NuVasive's $660,000 award) and denies Medtronic's bid for a permanent injunction barring NuVasive from selling the infringing spinal implants.

Medtronic
NuVasive

A federal judge let stand a $101.2 million jury verdict against NuVasive (NSDQ:NUVA) in a patent dispute with Medtronic (NYSE:MDT), but denied a Medtronic motion by to permanently bar NuVasive from selling the infringing spinal implants.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp